View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 8, 2016updated 14 Nov 2021 1:22pm

Deals this week: ITL Biomedical, Senzime AB, Abryx Inc

ITL Biomedical and BioMerieux Canada have entered into a distribution agreement to further develop ITL Biomedical’s Saftey SubCulture Unit (SCU).

ITL Biomedical and BioMerieux Canada have entered into a distribution agreement to further develop ITL Biomedical’s Saftey SubCulture Unit (SCU).

The agreement enables the two medical device companies to safely transfer bacteria positive samples through the SCU for further testing.

Senzime AB and Fukuda Denish Co. Ltd have entered a licensing agreement to commercialise Senzime’s TetraGraph system in Japan.

“The agreement enables the two partners to launch Senzime’s TetraGraph system in Japan by the end of 2017.”

According to the agreement, Senzime will receive $106.61m as license revenue-related milestones and royalties payments.

The agreement enables the two partners to launch Senzime’s TetraGraph system in Japan by the end of 2017.

Abryx Inc, a biosurgical products provider, has raised $10m in an equity financing round led by Canaan Partners, Mededge Inc and BB Biotech Ventures.

The company plans to invest the funds to handle the demand for its bone putty products and also to further develop its pipeline products.

Essex Woodlands Management Inc. has invested $15m in Metabolon, a medical diagnostics and services provider.

The company plans to invest the funds to repurchase a few shares that are held by existing investors.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network